Calcium & preeclampsia
This article was originally published in The Tan Sheet
Executive Summary
Daily supplementation with calcium does not prevent preeclampsia, but can reduce its severity, maternal morbidity and neonatal mortality, a study published in the March American Journal of Obstetrics & Gynecology finds. Sponsored by the World Health Organization, the study evaluated 8,325 women before their 20th week of pregnancy. All participants had a low dietary calcium intake of under 600 mg/day, less than half the recommended value during pregnancy. Of the group, 4,157 took 1.5 g calcium/day and 4,168 were assigned placebo for the duration of their pregnancy. Jose Villar, MD, World Health Organization, Geneva, Switzerland, et al., looked primarily at preeclampsia and preterm delivery, and secondarily at severe morbidity and maternal and neonatal mortality rates. Though no statistical difference was noted in the incidence of preeclampsia in the supplemental group, the "severe preeclamptic complications index" and "severe maternal morbidity and mortality index" was significantly lower, Villar et al. note...
You may also be interested in...
Deal Watch: AbbVie Teams With MedinCell On Long-Acting Injectables
Collaboration Edition: Including deals involving Evotec/Variant, Sanofi/IGM/Nurix, ABVC/OncoX and Harmony/Bioprojet, along with tech transfer agreements and deals in brief.
GE HealthCare Launches AI-Powered Voluson Ultrasound For Women’s Health
Voluson Signature 20 and 18 ultrasound provides clinicians with workflow efficiencies in detecting female reproductive health problems, especially those related to pregnancy.
CDER, CBER Not Seeing Hiring Slowdown Despite US FDA Warnings
FDA officials have said hiring could be slowed if an inflationary pay increase is not included in the agency budget, but CDER and CBER continue to add staff at a steady pace.